Plethora Solutions Ltd.
๐ฌ๐งUnited Kingdom
- Country
- ๐ฌ๐งUnited Kingdom
- Ownership
- Subsidiary
- Employees
- -
- Market Cap
- -
PSD502 in Subjects With Premature Ejaculation
- First Posted Date
- 2018-07-06
- Last Posted Date
- 2022-07-05
- Lead Sponsor
- Plethora Solutions Ltd
- Target Recruit Count
- 121
- Registration Number
- NCT03578783
- Locations
- ๐บ๐ธ
Manhattan Medical Research Practice, New York, New York, United States
๐บ๐ธMens Health Boston, Chestnut Hill, Massachusetts, United States
๐บ๐ธImagine Research of Palm Beach County, Boynton Beach, Florida, United States
A Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment of Premature Ejaculation
Phase 1
Completed
- Conditions
- Premature Ejaculation
- Interventions
- Drug: Intervention ADrug: Intervention B
- First Posted Date
- 2010-08-18
- Last Posted Date
- 2016-08-10
- Lead Sponsor
- Plethora Solutions Ltd
- Target Recruit Count
- 30
- Registration Number
- NCT01184105
A Safety and Tolerability Study of Administration of PSD502
Phase 1
Completed
- Conditions
- Premature Ejaculation
- Interventions
- Drug: Intervention ADrug: Intervention BDrug: Intervention CDrug: Intervention E
- First Posted Date
- 2010-08-17
- Last Posted Date
- 2016-08-10
- Lead Sponsor
- Plethora Solutions Ltd
- Target Recruit Count
- 21
- Registration Number
- NCT01183208
- Locations
- ๐ฌ๐ง
Bio-Kinetic Europe Limited, Belfast, United Kingdom
Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation
Phase 2
Completed
- Conditions
- Premature Ejaculation
- Interventions
- Drug: PSD502, contains a mixture of lidocaine and prilocaineDrug: Placebo
- First Posted Date
- 2007-11-12
- Last Posted Date
- 2016-09-26
- Lead Sponsor
- Plethora Solutions Ltd
- Target Recruit Count
- 256
- Registration Number
- NCT00556478
- Locations
- ๐บ๐ธ
Department of Urology, University of North Carolina, Chapel Hill, North Carolina, United States
Phase I Study of PSD502 (Lidocaine Prilocaine Spray) Applied to the Glans Penis up to Three Times a Day for 21 Days in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2007-06-08
- Last Posted Date
- 2010-07-15
- Lead Sponsor
- Plethora Solutions Ltd
- Target Recruit Count
- 16
- Registration Number
- NCT00483990
- Locations
- ๐บ๐ธ
PRA International - Clinical Pharmacology Center, Lenexa, Kansas, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath